College of Medicine, University of Florida, Gainesville, FL, USA.
Exactech Inc., Gainesville, FL, USA.
J Shoulder Elbow Surg. 2023 Apr;32(4):688-694. doi: 10.1016/j.jse.2022.12.012. Epub 2023 Jan 18.
Changes in pre- to postoperative outcome scores are often used to quantify success after anatomic total shoulder arthroplasty (aTSA). However, ceiling effects associated with many outcome scores limit the ability to differentiate success among high-functioning patients. The percentage maximal possible improvement (%MPI) was introduced to better stratify patient success; however, it is unclear if the 30% threshold first proposed correlates with perceived patient success across all outcome scores. The purpose of this study was to compare the proportion of patients that achieved the minimal clinically important difference (MCID) and %MPI for different outcome scores and to define the %MPI thresholds associated with patient satisfaction following primary aTSA.
A retrospective review was performed of an international shoulder arthroplasty database between 2003 and 2020. All primary aTSAs performed using a single implant system with minimum 2-year follow-up were reviewed. Pre- and postoperative outcome scores were evaluated for all patients to calculate improvement. The proportion of patients achieving the MCID and 30% MPI were determined for each outcome score. Thresholds for the minimal clinically important %MPI (MCI-%MPI) were calculated using an anchor-based method for each outcome score and stratified by age and sex.
1593 shoulders with a mean follow-up of 59.3 months were included. Outcome scores with known ceiling effects (Simple Shoulder Test [SST], American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form [ASES], University of California-Los Angeles shoulder score [UCLA]) had higher rates of patients achieving the 30% MPI but not the previously reported MCID. Inversely, outcome scores without significant ceiling effects (Constant and Shoulder Arthroplasty Smart [SAS] scores) had higher rates of patients achieving the MCID but not the 30% MPI. The MCI-%MPI differed among outcome scores, and mean values were as follows: 33% for the SST, 24% for the Constant score, 32% for the ASES score, 38% for the UCLA score, 30% for the Shoulder Pain and Disability Index score, and 33% for the SAS score. The MCI-%MPI increased with greater age (P < .003) and females had thresholds greater than or equal to males for all scores assessed, meaning that patients with higher thresholds required a greater fraction of the possible improvement for a given score to be satisfied.
The %MPI offers a simple method to quickly assess improvements across patient outcome scores. However, the %MPI that represents patient improvement after surgery is not uniformly the previously established 30% threshold. Surgeons should use score-specific estimates of the MCI-%MPI to gauge success when evaluating patients undergoing primary aTSA.
解剖型全肩关节置换术(aTSA)后,术前至术后的评分变化通常用于量化手术成功与否。然而,许多评分都存在天花板效应,限制了对高功能患者成功的区分。最大可能改善百分比(%MPI)的提出是为了更好地对患者的成功进行分层;然而,目前尚不清楚最初提出的 30%阈值是否与所有评分的患者感知成功相关。本研究的目的是比较不同评分中达到最小临床重要差异(MCID)和%MPI的患者比例,并确定与初次 aTSA 后患者满意度相关的%MPI 阈值。
对 2003 年至 2020 年间的国际肩关节置换数据库进行回顾性研究。对使用单一植入物系统且随访时间至少 2 年的所有初次 aTSA 进行了回顾。对所有患者进行术前和术后评分评估,以计算改善情况。确定了每个评分的 MCID 和 30%MPI 的患者比例。使用锚定法为每个评分计算了最小临床重要%MPI(MCI-%MPI)的阈值,并按年龄和性别进行分层。
共纳入 1593 例肩关节,平均随访 59.3 个月。具有已知天花板效应的评分(简单肩部测试[SST]、美国肩肘外科医生标准化肩部评估表[ASES]、加利福尼亚大学洛杉矶分校肩部评分[UCLA])的患者达到 30%MPI 的比例较高,但未达到先前报道的 MCID。相反,无明显天花板效应的评分(常数和肩关节置换智能[SAS]评分)的患者达到 MCID 的比例较高,但未达到 30%MPI。不同评分的 MCI-%MPI 不同,平均值如下:SST 为 33%,常数评分 24%,ASES 评分为 32%,UCLA 评分为 38%,肩部疼痛和残疾指数评分为 30%,SAS 评分为 33%。MCI-%MPI 随年龄的增加而增加(P<.003),女性的所有评分的阈值均高于男性,这意味着对于给定的评分,患者的阈值越高,所需的改善分数比例就越大。
%MPI 提供了一种快速评估患者术后不同评分改善情况的简单方法。然而,代表术后患者改善的%MPI并不统一为之前确立的 30%阈值。当评估接受初次 aTSA 的患者时,外科医生应使用特定评分的 MCI-%MPI 估计值来判断手术的成功。